News | October 29, 2021
Zydus Wellness PAT at Rs. 21.47 cr. in Q2FY22
Zydus Wellness Limited has reported consolidated financial results for the period ended September 30, 2021
Zydus Wellness Limited has reported consolidated financial results for the period ended September 30, 2021
Acute therapies continue to report strong growth compared to chronic ones.
A total of Rs 17,691.08 cr. invested in 157 new approved medical colleges since 2014
In collaboration with RAND Europe, the Vitality calculator predicts an individual's healthspan and future health risks
These pouches, manufactured at UFlex India plant, will be exported to American markets and will be majorly used for packing edible products
The initiative, with the support of MoHFW, will directly impact a population of more than 5.7 million that depend on the public health value chain across the 10 districts
These modules will act as a guide to doctors and health care workers to deal with post-Covid-19 issues
The first lot of IPV will be supplied to the government this month as per the requirement of the Health Ministry
The designation is based on results from the EMPEROR-Preserved phase III trial, which established Jardiance as the first therapy to show statistically significant improvement in heart failure outcomes in adults with heart failure with a preserved ejection fraction
Amptron’s R &D is based out of the US and this will enable Max to obtain US and other global certifications. Max will retain the right to market, sell and distribute the products in India.
Subscribe To Our Newsletter & Stay Updated
